Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Edelweiss Business Cycle Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseEdelweissHDFC
NAV₹9.5446₹23.6750
NAV date20 Nov 202620 Nov 2026
History2.3 years3.1 years
Expense ratio1.2%1.1%
StarsNot rated★★★★★
Growth Score—94.50

Returns

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+5.85%+12.97%
3 months+1.17%+7.13%
6 months+5.73%+17.84%
YTD+3.05%+33.73%
1 year+3.75%+32.20%
3 years (CAGR)—+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch−2.21%+31.83%

Risk

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility—15.8%
Downside volatility—8.5%
Sharpe—1.53
Sortino—2.86
Calmar—2.06
Return / risk—1.95
Deepest fall−26.39%−14.91%
Days to recover—126
Below its high−7.61%+0.00%

Against benchmark

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha—+7.54%
Beta—0.97
R²—85.0%
Up capture—108.9%
Down capture—71.0%
Tracking error—6.1%
Information ratio—1.17
Treynor—0.24

Consistency

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+20.97%+67.01%
Middle 1-year+1.01%+23.25%
Worst 1-year−14.64%+1.71%
1-year periods with a loss43.9%0.0%
Middle 3-year—+30.22%
Positive months—72.2%
Best day+4.77%+3.18%
Worst day−3.85%−3.61%
Worst 5% day−2.02%−1.51%
Positive days54.0%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR—+27.71%
1-year XIRR+9.07%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth